期刊文献+

我院2005年万古霉素类药物利用评价 被引量:6

Retrospective evaluation on the use of vancomycins in 2005 in our hospital
下载PDF
导出
摘要 目的:评价我院临床万古霉素类药物的应用情况。方法:参照卫生部颁布的《抗菌药物临床应用指导原则》,对我院2005年住院患者使用万古霉素类药物的237份病历共253例次,进行了用药情况的回顾性调查。结果:符合适应证标准79例(31.23%);符合剂量与用法标准216例(85.38%)。结论:通过药物利用评价,严格适应证,减少经验用药,有助于提高万古霉素类合理用药水平。 Objective: To evaluate the clinical use of vancomycins in our hospital. Methods : The retrospective survey on vancomycins in 237 inpatiens (253 prescriptions ) in 2005 was conducted according to The guiding principle of clinical use of antibacterials. Results:79 cases (31.23% of the orders) met the criteria of the therapeutic indication and 216 cases (85.38% of orders) met the criteria of dosage and administration. Conclusion:The measures ,such as restricting the indications and decreasing empirical application will be helpful in promoting the rational use of the agents.
作者 傅翔 侯华健
出处 《药学实践杂志》 CAS 2007年第3期181-183,共3页 Journal of Pharmaceutical Practice
关键词 万古霉素类药物 药物利用评价 vancomycins drug use evaluation
  • 相关文献

参考文献6

二级参考文献33

  • 1Fridkin S K. Vancmycin - intermediated and resistant Staphylococcus aureua: what the infecllons disease specialist needs to know [J]. Clin Infect Dis ,2001,32( 1 ) : 108.
  • 2Beatrz M,Susan B V, Boudewijn L M, et al. Increased production of penicillin- binding protein2, and decreased coagulase activity associated with glycopepfide resistance in Sthaphylococazs aureus [J]. Antimicrob Agents Chanother, 1997,41(8) :1788.
  • 3Finan J E,Acher G L,Pucci M J, et al. Role of penicillin - binding protein 4 in expression of vancomycin resistance among clinical isolates of oxaciUin - resistant Staphylococcus aureus. [J]. Antimicrob Agents Chemothet, 2001,45( 1 ):3070.
  • 4Sieradzki K, Robert R B, Haber S W, et al. The development of vancomycin resistance in a patient with methlcilln resistant Sthaphylococcua auruea infection [J]. N Engl J Med , 199,340(7) :517.
  • 5Perl T M. The threat of vancomycin resistance [J]. Am J Med, 1999,106(5A) :26S.
  • 6Blasi F, Tamm, M, Wilcox PA, et al. Frequency of the occurrence of atypical pathogens in hospitalized patients with CAP: a multi-country study[J]. Eur Respir J, 2004, 24: 242s.
  • 7Sanz F, Blanquer J, Briones M, et al. Etiology of community acquired pneumonia in the Valencian Community (Spain). A multicentric prospective one-year survey[J]. Eur Respir J, 2004, 24: 242s.
  • 8Ibrahim EH, Ward S, Sherman G, et al. Early-onset vs late-onset nosocomial pneumonia in the ICU setting[J]. Eur Respir J, 2004, 24: 231s.
  • 9Brum G, Melo R, Monteiro F, et al. Ventilator-associated pneumonia (VAP)[J]. Eur Respir J, 2004, 24: 547s.
  • 10Cavalcanti M, Ferrer R, Ferrer M, et al. The impact of inflammatory-response in the outcome of trauma patients with and without ventilator-associated pneumonia[J]. Eur Respir J, 2004, 24: 232s.

共引文献96

同被引文献40

引证文献6

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部